期刊文献+

促肾上腺皮质激素释放激素参与痛觉调控的作用 被引量:1

Role of corticotropin-releasing hormone in pain modulation
原文传递
导出
摘要 促肾上腺皮质激素释放激素(corticotropin-releasing hormone,CRH)作为哺乳动物应激反应的重要激素,在外周和中枢神经系统内对痛觉调节的过程中发挥着重要作用。CRH结合并激活其受体,通过减少外周伤害性刺激向中枢的传入、调节中枢神经元电活动的可塑性或者调节脊髓后角伤害性刺激等参与机体痛觉的调控。但是其作用机制尚需深入研究。此文综述CRH在外周、脊髓、中枢各水平的疼痛调节作用。 The stress neuropeptide, corticotropin-releasing hormone (CRH), distributes in central nervous system and inflammatory sites, and plays important role in pain modulation. Peripheral and central CRH may participate in pain and analgesia modulation via reducing the conduction of nociceptive stimulus towards nerve center and regulating the plasticity of central neuron electric activity, but the specific mechanisms are still unknown. This article reviews the roles of CRH in pain modulation at peripheral, spinal and central levels.
出处 《国际麻醉学与复苏杂志》 CAS 2008年第5期452-454,共3页 International Journal of Anesthesiology and Resuscitation
  • 相关文献

参考文献19

  • 1Dautzenberg FM, Hauger RL. The CRH peptide family and their receptors : yet more partners discovered. Trends pharmacol Sci, 2002, 23 : 71-77.
  • 2Yao M, Denver RJ. Regulation of vertebrate corticotropin-releasing factor genes. General and Comparative Endocrinology, 2007, 10: 1016- 1046.
  • 3Mastorakos G, Karoutsou El, Mizamtsidi M. Cortieotropin-releasing hormone and the immune/inflammatory response. European Journal of Endocrinology, 2006, 155: S77-S84.
  • 4Hemley CF, McCluskey A, Keller PA. Corticotropin releasing hormone-a GPCR drug target. Curr Drug Targets, 2007, 8: 105-115.
  • 5Grammatopoulos DK, Chrousos GP. Functional characteristics of CRH receptors and potential clinical applications of CRH receptor antagonists. Trends Endocrinol Metab, 2002, 13: 436-444.
  • 6Perrin MH, Vale WW. Cortiatropin-releasing factor receptors and their ligand family. Ann NY Acd Sci, 1999, 885 : 312-328.
  • 7Hillhouse EW, Grammatopoulos DK. The molecular mechanisms underlying the regulation of the biological activity of corticotrophin-releasing hormone receptors: implications for physiology and pathopgysiology. Endocrine Reviews, 2006, 27: 260-286.
  • 8Mousa SA, Bopaiah CP, Stein C, et al. Involvement of corticotropinreleasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain, 2003, 106: 297-307.
  • 9Schafer M, Mousa SA, Stein C. Corticotropin-releasing factor in antinociception and inflammation. Eur J Pharmacol, 1997, 323: 1-10.
  • 10Schafer M, Mousa SA, Zhang Q, et al. Expression of corticotropinreleasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci USA, 1996, 93 : 6096-6100.

同被引文献31

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部